Well, I guess we're going to find out just how ordinary the MIS sales have been. Hopefully, they'll surprise us with something positive!
TLS Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%